ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 189 filers reported holding ACORDA THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 1.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $1,035,000 | -30.9% | 52,987 | +1.6% | 0.56% | -25.7% |
| Q2 2018 | $1,497,000 | +16.7% | 52,163 | -3.8% | 0.76% | +10.0% |
| Q1 2018 | $1,283,000 | +26.4% | 54,230 | +14.6% | 0.69% | +21.5% |
| Q4 2017 | $1,015,000 | -27.8% | 47,313 | -14.7% | 0.57% | -29.7% |
| Q3 2017 | $1,406,000 | +28.4% | 55,435 | 0.0% | 0.81% | +23.2% |
| Q2 2017 | $1,095,000 | +16.6% | 55,435 | +8.7% | 0.66% | +14.9% |
| Q1 2017 | $939,000 | -3.3% | 51,013 | 0.0% | 0.57% | -10.2% |
| Q4 2016 | $971,000 | -13.6% | 51,013 | -4.7% | 0.64% | -21.6% |
| Q3 2016 | $1,124,000 | – | 53,508 | – | 0.81% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 428,000 | $8,046,000 | 1.90% |
| SCOPIA CAPITAL MANAGEMENT LP | 4,532,067 | $85,203,000 | 1.61% |
| DLD Asset Management, LP | 247,300 | $4,656,000 | 1.52% |
| Broadfin Capital, LLC | 644,153 | $12,110,000 | 1.34% |
| Perceptive Advisors | 720,000 | $13,536,000 | 0.96% |
| DLD Asset Management, LP | 135,493 | $2,547,000 | 0.83% |
| Malaga Cove Capital, LLC | 51,013 | $971,000 | 0.64% |
| Baker Brothers Advisors | 3,301,791 | $62,074,000 | 0.61% |
| Worth Venture Partners, LLC | 29,300 | $551,000 | 0.59% |
| Spark Investment Management LLC | 327,900 | $6,164,000 | 0.51% |